July 2024

New MTX-531 Research in Nature Cancer Highlights Promising Dual Inhibitor Strategy for Overcoming Cancer Resistance MINNEAPOLIS, July 11, 2024 /PRNewswire/ — MEKanistic Therapeutics Inc., a biotechnology company pioneering the development of next-generation kinase inhibitors for cancer treatme

Magazine made for you.

Featured:

No posts were found for provided query parameters.

Elsewhere: